期刊文献+

阿维A及雷公藤治疗重度斑块状银屑病疗效分析 被引量:6

原文传递
导出
摘要 阿维A和雷公藤是临床上治疗银屑病的常用药物,为分析二者治疗重度斑块状银屑病的疗效和安全性,我们应用阿维A胶囊(重庆华邦制药有限公司生产)和雷公藤(湖北三九黄石制药有限公司生产)单独和联合治疗重度斑块状银屑病,现报道如下。
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2011年第12期900-901,共2页 Chinese Journal of Dermatology
  • 相关文献

参考文献6

二级参考文献13

  • 1Mussi A,Bonifati C,Carducci M,et al.Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis.J Biol Regul Homeost Agents,1997,11:115-118.
  • 2Orfanos CE,Zouboulis CC,Almond-Roesler B,et al.Current use and future potential role of retinoids in dermatology.Drugs,1997,53:358-588.
  • 3Krueger G,Koo J,Lebwohl M,et al.The impact of psoriasis on quality of lifer results of a 1998 National Psoriasis Foundation patient-membership survey[J].Arch Dermatol,2001,137(3):280-284.
  • 4Mazzotti E,Picardi A,Sampogna F,et al.Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis[J].Br J Dermatol,2003,149(2):318-322.
  • 5Zaghloul SS,Goodfield MJ.Objective assessment of compliance with psoriasis treatment[J].Arch Dermatol,2004,140(4):408-414.
  • 6Feldman SR,Menter A,Koo JY.Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis[J].Br J Dermatol,2004,150(2):317-326.
  • 7Menter A,Kosinski M,Bresnahan BW,et al.Impact of efalizumab on psoriasis-specific patient-reported outcomes.Results from three randomized,placebo-controlled clinical trials of moderate to severe plaque psorlasis[J].J Drugs Dermatol,2004,3(1):27-38.
  • 8Feldman SR,Gordon KB,Bala M,et al.Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis:a double -blind placebo-controlled trial[J].Br J Dermatol,2005,152(5):954-960.
  • 9管汾.中药雷公藤治疗190例银屑病疗效观察[J].临床皮肤科杂志,1981,(2):91-91.
  • 10郑和义 王宏伟 王家璧 等.雷公藤治疗脓疱型银屑病7例[J].中国皮肤性病学杂志,1998,12(3):162-162.

共引文献245

同被引文献53

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部